Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Retinol may affect immune responses in people with frequent skin boils.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

An HIV patient with IRIS had rare syphilis symptoms affecting skin, eyes, and nerves.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

People with acne have more CD4+ immune cells in their skin than healthy people.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.